
Growing Up with a Disease That Doesn’t Let You
Editor’s Note: This article was originally written and shared with Patient Worthy by Mamie Hertel. Minor formatting edits have been made. To see the article

Editor’s Note: This article was originally written and shared with Patient Worthy by Mamie Hertel. Minor formatting edits have been made. To see the article

Employed senior caregivers and other family caregivers often carry two full-time roles at once, and the work-life balance challenges can feel relentless. Meetings, medication schedules,

When I met my husband, Costa, he had vitiligo. At the time, we saw it as one condition that we would have to understand and

This Lung Cancer Awareness Month, the Alliance for Clinical Trials in Oncology—a National Cancer Institute -sponsored national network spanning 26,000 cancer specialists across North America—is

Editor’s Note: This article was originally written by Jessica Lynn for Rareatives. To see the article in its original format, please click here. Ask Brighton’s

As shared on EurekAlert, a study of children and adults newly diagnosed with MOGAD found that most recovered fully. Fewer than 12% had another attack

Editor’s Note: This article was originally written and submitted by Cami Clune. As a full-time musician, my life is anything but predictable. I perform over

The under-the-skin treatment received accelerated approval after a clinical trial found that tumors shrank in some participants whose cancer had returned or spread after earlier

As reported on PharmaBiz, the US Food and Drug Administration (FDA) has approved Roche’s Enspryng (satralizumab) for the treatment of adults with thyroid eye disease

Mānuka honey has grown from a niche natural remedy to a popular kitchen staple almost overnight. A few years ago, you could only find it

As shared on PR Newswire, SiOxMed, a company that develops silica-based biomaterials for wound care and skin health, has partnered with Gifthealth, a digital pharmacy,

Chronic kidney disease (CKD) affects an estimated 850 million people worldwide, or roughly 9.1% of the global population, according to the National Institutes of Health.

Voceryq is designed to help the immune system fight the HPV types that cause RRP. In a small clinical trial, some adults went a year

Efgartigimod produced a significantly greater improvement than placebo in patients with autoimmune myositis in the Phase 3 ALKIVIA trial, according to results announced by argenx

In a 52-week trial, 85.3% of people with primary biliary cholangitis who took IQIRVO had an ALP result in the normal range, compared with 23.3%

As reported on Business Wire, new data from Merck suggest that efinopegdutide, an investigational dual GLP-1/glucagon receptor agonist, may offer a promising new approach for

About Dravet Syndrome Dravet syndrome—a rare, genetically-based disorder also known as Severe Myoclonic Epilepsy of Infancy—is characterized by epileptic seizures that begin within the first

Editor’s Note: This Veteran’s Day, Patient Worthy is honored to bring you this submission by John H. The U.S. military was our family business. It
No more posts
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
What best describes you when it comes to rare disease? (check all that apply)
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.